5-Minute test could revolutionize dementia detection in Doctor's offices
NCT ID NCT05515224
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a quick, 5-minute cognitive assessment called the 5-Cog to help primary care doctors identify older adults with undiagnosed dementia or mild cognitive impairment. The trial will involve 6,600 patients aged 65 and older across 22 clinics in the Bronx and Indiana. The goal is to see if this simple tool leads to more new diagnoses and better follow-up care, especially in communities that often miss out on early detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
5-Cog cognitive assessment battery
What this could lead to
If successful, this could lead to a simple, quick tool that helps doctors spot early signs of dementia more often, especially in groups that are currently underdiagnosed.
What could go wrong
This is a pragmatic trial testing a screening tool, not a treatment. It may not improve patient outcomes beyond diagnosis, and results may vary across different clinic settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Albert Einstein College of Medicine
RECRUITINGThe Bronx, New York, 10461, United States
Contact Email: •••••@•••••
Contact
-
Indiana University
RECRUITINGBloomington, Indiana, 47405, United States
Contact
Contact